Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 9/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 8/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.60 |
| ▸ | GAA | P10253 | 6/20 | 0.60 |
| ▸ | MEN1 | O00255 | 6/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.60 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.60 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.60 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.60 |
| ▸ | TSHR | P16473 | 1/20 | 0.60 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.60 |
| ▸ | DRD3 | P35462 | 1/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.60 |
| ▸ | CASP6 | P55212 | 2/20 | 0.58 |
| ▸ | LMNA | P02545 | 2/20 | 0.57 |
| ▸ | HTT | P42858 | 2/20 | 0.57 |
| ▸ | APP | P05067 | 6/20 | 0.54 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29851934 | 1.00 | MAPT (0.60) | MAPTKMT2AALDH1A1GAAMEN1 | |
| SCHEMBL10594920 | 0.87 | MAPT (0.57) | MAPTKMT2AALDH1A1GAAMEN1 | |
| SCHEMBL4664740 | 0.83 | MAPT (0.64) | MAPTKMT2AALDH1A1GAAMEN1 | |
| SCHEMBL17261660 | 0.81 | MAPT (0.62) | MAPTKMT2AALDH1A1GAAMEN1 | |
| SCHEMBL9770328 | 0.81 | MAPT (0.66) | MAPTKMT2AALDH1A1GAAMEN1 | |
| SCHEMBL10435333 | 0.81 | MAPT (0.67) | MAPTKMT2AALDH1A1GAAMEN1 | |
| SCHEMBL3533968 | 0.80 | KMT2A (0.60) | MAPTKMT2AALDH1A1GAAMEN1 | |
| SCHEMBL14759038 | 0.80 | MAPT (0.60) | MAPTKMT2AALDH1A1GAAMEN1 | |
| SCHEMBL11382157 | 0.80 | MAPT (0.44) | MAPTKMT2AALDH1A1GAAMEN1 | |
| SCHEMBL4661622 | 0.80 | MAPT (0.60) | MAPTKMT2AALDH1A1GAAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3105807-B1 | GRAPHENE COMPOSITE, METHOD FOR PRODUCING GRAPHENE COMPOSITE AND ELECTRODE FOR LITHIUM ION BATTERY CONTAINING GRAPHENE COMPOSITE | TORAY INDUSTRIES (JP) | 2019-04-10 | — | — | EP | claimed |
| US-10199654-B2 | Graphene composite, method for producing graphene composite and electrode for lithium ion battery containing graphene composite | TORAY INDUSTRIES, INC. (JP) | 2019-02-05 | — | — | US | claimed |
| EP-3105807-A1 | GRAPHENE COMPOSITE, METHOD FOR PRODUCING GRAPHENE COMPOSITE AND ELECTRODE FOR LITHIUM ION BATTERY CONTAINING GRAPHENE COMPOSITE | Toray Industries, Inc. (JP) | 2016-12-21 | — | — | EP | claimed |
| CN-114920753-B | 6-fluoro-dihydropyran [2,3-c ] pyrazole derivative and synthetic method and application thereof | 华南理工大学 | 2023-06-20 | — | — | CN | disclosed |
| CN-114920753-A | 6-fluoro-dihydropyrano [2,3-c ] pyrazole derivative and synthetic method and application thereof | 华南理工大学 | 2022-08-19 | — | — | CN | disclosed |
| US-20220037663-A1 | ELECTRODE FOR SECONDARY BATTERIES AND LITHIUM ION SECONDARY BATTERY | TORAY INDUSTRIES, INC. (JP) | 2022-02-03 | — | — | US | disclosed |
| EP-3859826-A1 | ELECTRODE FOR SECONDARY BATTERIES AND LITHIUM ION SECONDARY BATTERY | Toray Industries, Inc. (JP) | 2021-08-04 | — | — | EP | disclosed |
| US-20210128529-A1 | DRUG CONTAINING PYRAZOLONE DERIVATIVE | NOBELPHARMA CO., LTD. (JP) | 2021-05-06 | — | — | US | disclosed |
| CN-112714970-A | Electrode for secondary battery and lithium ion secondary battery | 东丽株式会社 | 2021-04-27 | — | — | CN | disclosed |
| CN-112118839-A | Pyrazolone derivative-containing drug | 耐贝医药株式会社 | 2020-12-22 | — | — | CN | disclosed |
| CN-105940537-B | Graphene composite, preparation method of graphene composite and electrode for lithium ion battery containing graphene composite | 东丽先端材料研究开发（中国）有限公司 | 2020-12-08 | — | — | CN | disclosed |
| EP-1294378-A2 | THROMBOPOIETIN MIMETICS | SMITHKLINE BEECHAM CORPORATION (US) | 2003-03-26 | — | — | EP | disclosed |
| WO-2001089457-A2 | THROMBOPOIETIN MIMETICS | SMITHKLINE BEECHAM CORPORATION (US) | 2001-11-29 | — | — | WO | disclosed |
| US-RE35801-E | PYRAZOLONE DERIVATIVES | MITSUBISHI CHEMICAL CORPORATION (JP) | 1998-05-19 | — | — | US | disclosed |
| EP-0208874-B1 | PROPHYLACTIC AND THERAPEUTIC AGENT FOR CIRCULATORY DISORDERS | MITSUBISHI KASEI CORPORATION (JP) | 1993-03-24 | — | — | EP | disclosed |
| EP-0138749-B1 | PROCESS FOR MASS DYEING SYNTHETIC POLYAMIDES | CIBA-GEIGY AG (CH) | 1989-08-23 | — | — | EP | disclosed |
| US-4857542-A | INHIBITOR AGAINST LIPID PEROXIDATION | MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JP) | 1989-08-15 | — | — | US | disclosed |
| EP-0208874-A1 | Prophylactic and therapeutic agent for circulatory disorders | MITSUBISHI KASEI CORPORATION (JP) | 1987-01-21 | — | — | EP | disclosed |
| US-4527994-A | Process for mass-coloring nylon with 1:2 chromium complex azo dye | CIBA-GEIGY CORPORATION (US) | 1985-07-09 | — | — | US | disclosed |
| EP-0138749-A2 | Process for mass dyeing synthetic polyamides | CIBA-GEIGY AG (CH) | 1985-04-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210128529-A1 | DRUG CONTAINING PYRAZOLONE DERIVATIVE | CYP11B2, CYP3A5, DPYD | MAPT 4271/4885KMT2A 1306/4885ALDH1A1 285/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.